C. Hoogerbrugge

发表

Preclinical and Clinical In Vitro In Vivo Correlation of an hGH Dextran Microsphere Formulation

W. Hennink, D. Crommelin, R. Verrijk, 2007, Pharmaceutical Research.

Cellular growth in organs of dwarf mice during treatment with growth hormone, thyroxine and plasma fractions containing somatomedin activity.

J. L. Brande, C. Hoogerbrugge, M. Feijlbrief, 1982 .

Recombinant insulin-like growth factor-II inhibits the growth-stimulating effect of growth hormone on the liver of Snell dwarf mice.

J. van den Brande, C. Kuper, C. Hoogerbrugge, 1994, Endocrinology.

Insulinlike growth factor—ii/mannose 6‐phosphate receptor is expressed on ccl4‐exposed rat fat‐storing cells and facilitates activation of latent transforming growth factor‐β in cocultures with sinusoidal endothelial cells

E. Wisse, V. Rogiers, T. Niki, 1995 .

Antibodies directed against the E region of pro-insulin-like growth factor-II used to evaluate non-islet cell tumor-induced hypoglycemia.

J. van Doorn, K. Hoekman, C. Hoogerbrugge, 2002, Clinical chemistry.

The presence of classical insulin-like growth factor (IGF) type-I and -II receptors on mouse osteoblasts: autocrine/paracrine growth effect of IGFs?

S. Duursma, C. Hoogerbrugge, S. van Buul-Offers, 1990, The Journal of endocrinology.

Differential regulation of IGF-binding proteins in rabbit costal chondrocytes by IGF-I and dexamethasone.

C. Hoogerbrugge, S. van Buul-Offers, J. Koedam, 2000, The Journal of endocrinology.

Mutations in the NSD1 gene in patients with Sotos syndrome associate with endocrine and paracrine alterations in the IGF system.

H. V. van Duyvenvoorde, J. Wit, M. Karperien, 2004, European journal of endocrinology.

Skin fibroblasts of children with idiopathic short stature show an increased mitogenic response to IGF‐I and secrete more IGFBP‐3

A. Zwinderman, J. Wit, D. Ouwens, 2002, Clinical endocrinology.

Therapeutic agents produced by genetic engineering: Quo vadis? The example of growth hormone and its releasing factor. Satellite symposium. Toulouse-Labège, May 29-30, 1985.

N. Ling, G. Sassolas, A. Caufriez, 1986, Hormone Research.

Serum somatomedin activity and cartilage metabolism in acutely fasted, chronically malnourished, and refed rats.

J. van den Brande, D. Price, C. Hoogerbrugge, 1979, Endocrinology.

Primary sequences of insulin-like growth factors 1 and 2 isolated from porcine plasma.

S. Bayne, J. van den Brande, C. Hoogerbrugge, 1991, Journal of chromatography.

Effect of growth hormone and peptide fractions containing somatomedin activity on growth and cartilage metabolism of snell dwarfmice.

J. L. Brande, C. Hoogerbrugge, S. Buul-Offers, 1979 .

Co-administration of IGF-binding protein-3 differentially inhibits the IGF-I-induced total body and organ growth of Snell dwarf mice.

J. van den Brande, C. Hoogerbrugge, S. van Buul-Offers, 1995, Progress in growth factor research.

Isolation and partial characterization of IGF-like peptides from Cohn fraction IV of human plasma.

K. Beyreuther, P. Roepstorff, J. van den Brande, 1990, Acta endocrinologica.

Plasma Insulin-Like Growth Factors (IGFs), IGF-Binding Proteins (IGFBPs), Acid-Labile Subunit (ALS) and IGFBP-3 Proteolysis in Individuals with Clinical Characteristics of Sotos Syndrome

J. Wit, M. Karperien, L. de Boer, 2004, Journal of pediatric endocrinology & metabolism : JPEM.

Characterization of O-glycosylated precursors of insulin-like growth factor II by matrix-assisted laser desorption/ionization mass spectrometry.

J. van der Greef, J. van den Brande, U. Tjaden, 1996, Journal of mass spectrometry : JMS.

Evidence for carrier ampholyte-peptide interactions during somatomedin purification

J. L. Brande, C. Hoogerbrugge, J. A. Bakker, 1981 .

Human insulin-like growth factor (IGF) binding protein-1 inhibits IGF-I-stimulated body growth but stimulates growth of the kidney in snell dwarf mice.

J. W. Neck, J. V. van Neck, S. Drop, 2000, Endocrinology.

Insulin-like growth factor binding proteins-3 and -5 form sodium dodecyl sulfate-stable multimers.

C. Hoogerbrugge, S. van Buul-Offers, J. Koedam, 1997, Biochemical and biophysical research communications.

Insulin-like growth factor-binding protein-3 protease activity in Snell normal and Pit-1 deficient dwarf mice.

C. Hoogerbrugge, S. van Buul-Offers, J. Koedam, 1998, The Journal of endocrinology.

Characterization of growth factor activity produced by fetal mouse osteoblasts.

E. J. V. van Zoelen, S. Duursma, C. Hoogerbrugge, 1990, The Journal of endocrinology.

Insulin-like growth factors-I and -II and their binding proteins during postnatal development of dwarf Snell mice before and during growth hormone and thyroxine therapy.

J. van den Brande, C. Hoogerbrugge, S. van Buul-Offers, 1994, Journal of Endocrinology.

Effects of a single cleavage in insulin-like growth factors I and II on binding to receptors, carrier proteins and antibodies.

J. van den Brande, C. Hoogerbrugge, J. Jansen, 1990, The Biochemical journal.